DB06643The risk or severity of adverse effects can be increased when Denosumab is combined with Fluprednidene.
DB00008The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluprednidene.
DB00011The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluprednidene.
DB00018The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluprednidene.
DB00022The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluprednidene.
DB00033The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluprednidene.
DB00034The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluprednidene.
DB00056The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluprednidene.
DB00059The risk or severity of adverse effects can be increased when Pegaspargase is combined with Fluprednidene.
DB00068The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Fluprednidene.
DB00069The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Fluprednidene.
DB00073The risk or severity of adverse effects can be increased when Rituximab is combined with Fluprednidene.
DB00074The risk or severity of adverse effects can be increased when Basiliximab is combined with Fluprednidene.
DB00075The risk or severity of adverse effects can be increased when Muromonab is combined with Fluprednidene.
DB00078The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Fluprednidene.
DB00081The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluprednidene.
DB00087The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Fluprednidene.
DB00092The risk or severity of adverse effects can be increased when Alefacept is combined with Fluprednidene.
DB00095The risk or severity of adverse effects can be increased when Efalizumab is combined with Fluprednidene.
DB00098The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Fluprednidene.
DB00105The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Fluprednidene.
DB00111The risk or severity of adverse effects can be increased when Daclizumab is combined with Fluprednidene.
DB00112The risk or severity of adverse effects can be increased when Bevacizumab is combined with Fluprednidene.
DB00120The risk or severity of adverse effects can be increased when Phenylalanine is combined with Fluprednidene.
DB00242The risk or severity of adverse effects can be increased when Cladribine is combined with Fluprednidene.
DB00262The risk or severity of adverse effects can be increased when Carmustine is combined with Fluprednidene.
DB00276The risk or severity of adverse effects can be increased when Amsacrine is combined with Fluprednidene.
DB00290The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluprednidene.
DB00291The risk or severity of adverse effects can be increased when Chlorambucil is combined with Fluprednidene.
DB00293The risk or severity of adverse effects can be increased when Raltitrexed is combined with Fluprednidene.
DB00305The risk or severity of adverse effects can be increased when Mitomycin is combined with Fluprednidene.
DB00307The risk or severity of adverse effects can be increased when Bexarotene is combined with Fluprednidene.
DB00322The risk or severity of adverse effects can be increased when Floxuridine is combined with Fluprednidene.
DB00352The risk or severity of adverse effects can be increased when Tioguanine is combined with Fluprednidene.
DB00380The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Fluprednidene.
DB00428The risk or severity of adverse effects can be increased when Streptozocin is combined with Fluprednidene.
DB00432The risk or severity of adverse effects can be increased when Trifluridine is combined with Fluprednidene.
DB00441The risk or severity of adverse effects can be increased when Gemcitabine is combined with Fluprednidene.
DB00445The risk or severity of adverse effects can be increased when Epirubicin is combined with Fluprednidene.
DB00446The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluprednidene.
DB00480The risk or severity of adverse effects can be increased when Lenalidomide is combined with Fluprednidene.
DB00488The risk or severity of adverse effects can be increased when Altretamine is combined with Fluprednidene.
DB00495The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluprednidene.
DB00526The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Fluprednidene.
DB00544The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fluprednidene.
DB00550The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Fluprednidene.
DB00552The risk or severity of adverse effects can be increased when Pentostatin is combined with Fluprednidene.
DB00601The risk or severity of adverse effects can be increased when Linezolid is combined with Fluprednidene.
DB00631The risk or severity of adverse effects can be increased when Clofarabine is combined with Fluprednidene.
DB00642The risk or severity of adverse effects can be increased when Pemetrexed is combined with Fluprednidene.
DB00688The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Fluprednidene.
DB00755The risk or severity of adverse effects can be increased when Tretinoin is combined with Fluprednidene.
DB00763The risk or severity of adverse effects can be increased when Methimazole is combined with Fluprednidene.
DB00851The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fluprednidene.
DB00853The risk or severity of adverse effects can be increased when Temozolomide is combined with Fluprednidene.
DB00859The risk or severity of adverse effects can be increased when Penicillamine is combined with Fluprednidene.
DB00928The risk or severity of adverse effects can be increased when Azacitidine is combined with Fluprednidene.
DB00958The risk or severity of adverse effects can be increased when Carboplatin is combined with Fluprednidene.
DB00970The risk or severity of adverse effects can be increased when Dactinomycin is combined with Fluprednidene.
DB00993The risk or severity of adverse effects can be increased when Azathioprine is combined with Fluprednidene.
DB01005The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Fluprednidene.
DB01024The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Fluprednidene.
DB01030The risk or severity of adverse effects can be increased when Topotecan is combined with Fluprednidene.
DB01033The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Fluprednidene.
DB01041The risk or severity of adverse effects can be increased when Thalidomide is combined with Fluprednidene.
DB01042The risk or severity of adverse effects can be increased when Melphalan is combined with Fluprednidene.
DB01073The risk or severity of adverse effects can be increased when Fludarabine is combined with Fluprednidene.
DB01099The risk or severity of adverse effects can be increased when Flucytosine is combined with Fluprednidene.
DB01101The risk or severity of adverse effects can be increased when Capecitabine is combined with Fluprednidene.
DB01168The risk or severity of adverse effects can be increased when Procarbazine is combined with Fluprednidene.
DB01169The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Fluprednidene.
DB01177The risk or severity of adverse effects can be increased when Idarubicin is combined with Fluprednidene.
DB01196The risk or severity of adverse effects can be increased when Estramustine is combined with Fluprednidene.
DB01204The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluprednidene.
DB01206The risk or severity of adverse effects can be increased when Lomustine is combined with Fluprednidene.
DB01257The risk or severity of adverse effects can be increased when Eculizumab is combined with Fluprednidene.
DB01262The risk or severity of adverse effects can be increased when Decitabine is combined with Fluprednidene.
DB01280The risk or severity of adverse effects can be increased when Nelarabine is combined with Fluprednidene.
DB01423The risk or severity of adverse effects can be increased when Stepronin is combined with Fluprednidene.
DB01611The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Fluprednidene.
DB01816The risk or severity of adverse effects can be increased when Castanospermine is combined with Fluprednidene.
DB02546The risk or severity of adverse effects can be increased when Vorinostat is combined with Fluprednidene.
DB02806The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Fluprednidene.
DB03523The risk or severity of adverse effects can be increased when Brequinar is combined with Fluprednidene.
DB04951The risk or severity of adverse effects can be increased when Pirfenidone is combined with Fluprednidene.
DB05258The risk or severity of adverse effects can be increased when Interferon alfa is combined with Fluprednidene.
DB05259The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluprednidene.
DB05260The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Fluprednidene.
DB05459The risk or severity of adverse effects can be increased when Briakinumab is combined with Fluprednidene.
DB05472The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Fluprednidene.
DB06612The risk or severity of adverse effects can be increased when Mepolizumab is combined with Fluprednidene.
DB06662The risk or severity of adverse effects can be increased when Abetimus is combined with Fluprednidene.
DB06681The risk or severity of adverse effects can be increased when Belatacept is combined with Fluprednidene.
DB06769The risk or severity of adverse effects can be increased when Bendamustine is combined with Fluprednidene.
DB06813The risk or severity of adverse effects can be increased when Pralatrexate is combined with Fluprednidene.
DB08059The risk or severity of adverse effects can be increased when Wortmannin is combined with Fluprednidene.
DB08871The risk or severity of adverse effects can be increased when Eribulin is combined with Fluprednidene.
DB08879The risk or severity of adverse effects can be increased when Belimumab is combined with Fluprednidene.
DB08880The risk or severity of adverse effects can be increased when Teriflunomide is combined with Fluprednidene.
DB08889The risk or severity of adverse effects can be increased when Carfilzomib is combined with Fluprednidene.
DB08908The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Fluprednidene.
DB08935The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Fluprednidene.
DB09033The risk or severity of adverse effects can be increased when Fluprednidene is combined with Vedolizumab.
DB09052The risk or severity of adverse effects can be increased when Fluprednidene is combined with Blinatumomab.
DB09077The risk or severity of adverse effects can be increased when Fluprednidene is combined with Dinutuximab.
DB09082The risk or severity of adverse effects can be increased when Fluprednidene is combined with Vilanterol.
DB09122The risk or severity of adverse effects can be increased when Fluprednidene is combined with Peginterferon beta-1a.
DB09312The risk or severity of adverse effects can be increased when Fluprednidene is combined with Antilymphocyte immunoglobulin (horse).
DB11569The risk or severity of adverse effects can be increased when Fluprednidene is combined with Ixekizumab.
DB11580The risk or severity of adverse effects can be increased when Fluprednidene is combined with Ravulizumab.
DB11616The risk or severity of adverse effects can be increased when Fluprednidene is combined with Pirarubicin.
DB11693The risk or severity of adverse effects can be increased when Fluprednidene is combined with Voclosporin.
DB11708The risk or severity of adverse effects can be increased when Fluprednidene is combined with Peficitinib.
DB11767The risk or severity of adverse effects can be increased when Fluprednidene is combined with Sarilumab.
DB11776The risk or severity of adverse effects can be increased when Fluprednidene is combined with Brodalumab.
DB11803The risk or severity of adverse effects can be increased when Fluprednidene is combined with Sirukumab.
DB11834The risk or severity of adverse effects can be increased when Fluprednidene is combined with Guselkumab.
DB12612The risk or severity of adverse effects can be increased when Fluprednidene is combined with Ozanimod.
DB12617The risk or severity of adverse effects can be increased when Fluprednidene is combined with Mizoribine.
DB12692The risk or severity of adverse effects can be increased when Fluprednidene is combined with Gusperimus.
DB12814The risk or severity of adverse effects can be increased when Fluprednidene is combined with Cepeginterferon alfa-2B.
DB12902The risk or severity of adverse effects can be increased when Fluprednidene is combined with Trofosfamide.
DB12947The risk or severity of adverse effects can be increased when Fluprednidene is combined with Doxifluridine.
DB12991The risk or severity of adverse effects can be increased when Fluprednidene is combined with Deoxyspergualin.
DB12996The risk or severity of adverse effects can be increased when Fluprednidene is combined with Acteoside.
DB13014The risk or severity of adverse effects can be increased when Fluprednidene is combined with Hypericin.
DB13068The risk or severity of adverse effects can be increased when Fluprednidene is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
DB13241The risk or severity of adverse effects can be increased when Fluprednidene is combined with Begelomab.
DB14066The risk or severity of adverse effects can be increased when Fluprednidene is combined with Tetrandrine.
DB14219The risk or severity of adverse effects can be increased when Fluprednidene is combined with Monomethyl fumarate.
DB14762The risk or severity of adverse effects can be increased when Fluprednidene is combined with Risankizumab.
DB14919The risk or severity of adverse effects can be increased when Fluprednidene is combined with Rozanolixizumab.
DB15253The risk or severity of adverse effects can be increased when Fluprednidene is combined with Bleselumab.
DB00005The risk or severity of adverse effects can be increased when Etanercept is combined with Fluprednidene.
DB00026The risk or severity of adverse effects can be increased when Anakinra is combined with Fluprednidene.
DB00051The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluprednidene.
DB00065The risk or severity of adverse effects can be increased when Infliximab is combined with Fluprednidene.
DB01281The risk or severity of adverse effects can be increased when Abatacept is combined with Fluprednidene.
DB04956The risk or severity of adverse effects can be increased when Afelimomab is combined with Fluprednidene.
DB05676The risk or severity of adverse effects can be increased when Apremilast is combined with Fluprednidene.
DB06168The risk or severity of adverse effects can be increased when Canakinumab is combined with Fluprednidene.
DB06273The risk or severity of adverse effects can be increased when Tocilizumab is combined with Fluprednidene.
DB06372The risk or severity of adverse effects can be increased when Rilonacept is combined with Fluprednidene.
DB06674The risk or severity of adverse effects can be increased when Golimumab is combined with Fluprednidene.
DB08904The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Fluprednidene.
DB09029The risk or severity of adverse effects can be increased when Fluprednidene is combined with Secukinumab.
DB09036The risk or severity of adverse effects can be increased when Fluprednidene is combined with Siltuximab.
DB14724The risk or severity of adverse effects can be increased when Fluprednidene is combined with Emapalumab.
DB01394The risk or severity of adverse effects can be increased when Colchicine is combined with Fluprednidene.
DB00180The risk or severity of adverse effects can be increased when Flunisolide is combined with Fluprednidene.
DB00394The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Fluprednidene.
DB00443The risk or severity of adverse effects can be increased when Betamethasone is combined with Fluprednidene.
DB00588The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fluprednidene.
DB00591The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Fluprednidene.
DB00620The risk or severity of adverse effects can be increased when Triamcinolone is combined with Fluprednidene.
DB00635The risk or severity of adverse effects can be increased when Prednisone is combined with Fluprednidene.
DB00687The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Fluprednidene.
DB00860The risk or severity of adverse effects can be increased when Prednisolone is combined with Fluprednidene.
DB00959The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Fluprednidene.
DB01222The risk or severity of adverse effects can be increased when Budesonide is combined with Fluprednidene.
DB01234The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluprednidene.
DB01285The risk or severity of adverse effects can be increased when Corticotropin is combined with Fluprednidene.
DB01380The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Fluprednidene.
DB01384The risk or severity of adverse effects can be increased when Paramethasone is combined with Fluprednidene.
DB01410The risk or severity of adverse effects can be increased when Ciclesonide is combined with Fluprednidene.
DB04630The risk or severity of adverse effects can be increased when Aldosterone is combined with Fluprednidene.
DB08906The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluprednidene.
DB09091The risk or severity of adverse effects can be increased when Fluprednidene is combined with Tixocortol.
DB09378The risk or severity of adverse effects can be increased when Fluprednidene is combined with Fluprednisolone.
DB09383The risk or severity of adverse effects can be increased when Fluprednidene is combined with Meprednisone.
DB11487The risk or severity of adverse effects can be increased when Fluprednidene is combined with Dexamethasone isonicotinate.
DB11529The risk or severity of adverse effects can be increased when Fluprednidene is combined with Melengestrol.
DB11921The risk or severity of adverse effects can be increased when Fluprednidene is combined with Deflazacort.
DB13003The risk or severity of adverse effects can be increased when Fluprednidene is combined with Cortivazol.
DB13208The risk or severity of adverse effects can be increased when Fluprednidene is combined with Prednylidene.
DB13223The risk or severity of adverse effects can be increased when Fluprednidene is combined with Fluocortin.
DB13491The risk or severity of adverse effects can be increased when Fluprednidene is combined with Fluperolone.
DB13843The risk or severity of adverse effects can be increased when Fluprednidene is combined with Cloprednol.
DB13856The risk or severity of adverse effects can be increased when Fluprednidene is combined with Fluclorolone.
DB13867The risk or severity of adverse effects can be increased when Fluprednidene is combined with Fluticasone.
DB14512The risk or severity of adverse effects can be increased when Fluprednidene is combined with Mometasone furoate.
DB14539The risk or severity of adverse effects can be increased when Fluprednidene is combined with Hydrocortisone acetate.
DB14545The risk or severity of adverse effects can be increased when Fluprednidene is combined with Hydrocortisone succinate.
DB00694The risk or severity of adverse effects can be increased when Daunorubicin is combined with Fluprednidene.
DB00987The risk or severity of adverse effects can be increased when Cytarabine is combined with Fluprednidene.
DB05015The risk or severity of adverse effects can be increased when Belinostat is combined with Fluprednidene.
DB01013The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Fluprednidene.
DB01047The risk or severity of adverse effects can be increased when Fluocinonide is combined with Fluprednidene.
DB14540The risk or severity of adverse effects can be increased when Fluprednidene is combined with Hydrocortisone butyrate.
DB00547The risk or severity of adverse effects can be increased when Desoximetasone is combined with Fluprednidene.
DB00764The risk or severity of adverse effects can be increased when Mometasone is combined with Fluprednidene.
DB08971The risk or severity of adverse effects can be increased when Fluprednidene is combined with Fluocortolone.
DB11750The risk or severity of adverse effects can be increased when Fluprednidene is combined with Clobetasol.
DB00619The risk or severity of adverse effects can be increased when Fluprednidene is combined with Imatinib.
DB09053The risk or severity of adverse effects can be increased when Fluprednidene is combined with Ibrutinib.
DB00324The risk or severity of adverse effects can be increased when Fluorometholone is combined with Fluprednidene.
DB09095The risk or severity of adverse effects can be increased when Fluprednidene is combined with Difluocortolone.
DB00108The risk or severity of adverse effects can be increased when Fluprednidene is combined with Natalizumab.
DB00337The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluprednidene.
DB01656Roflumilast may increase the immunosuppressive activities of Fluprednidene.
DB06688The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Fluprednidene.
DB09063The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Ceritinib.
DB00041The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluprednidene.
DB09067The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluprednidene.
DB01609The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Fluprednidene is combined with Deferasirox.
DB00070The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Fluprednidene.
DB06205The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Fluprednidene.
DB14740The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluprednidene.
DB00681The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Amphotericin B.
DB00221The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Isoetharine.
DB00368The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Norepinephrine.
DB00397The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Phenylpropanolamine.
DB00668The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Epinephrine.
DB00816The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Orciprenaline.
DB00841The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Dobutamine.
DB00867The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Ritodrine.
DB00901The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Bitolterol.
DB00938The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Salmeterol.
DB00983The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Formoterol.
DB01001The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Salbutamol.
DB01064The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Isoprenaline.
DB01102The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Arbutamine.
DB01274The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Arformoterol.
DB01288The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Fenoterol.
DB01291The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Pirbuterol.
DB01363The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Ephedra sinica root.
DB01366The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Procaterol.
DB01407The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Clenbuterol.
DB04846The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Celiprolol.
DB05039The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Indacaterol.
DB06262The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Droxidopa.
DB06814The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Protokylol.
DB08957The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Hexoprenaline.
DB09080The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Olodaterol.
DB09273The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Doxofylline.
DB11124The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Racepinephrine.
DB11587The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Etafedrine.
DB11871The risk or severity of hypokalemia can be increased when Fluprednidene is combined with PF-00610355.
DB12100The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Abediterol.
DB12526The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Batefenterol.
DB13139The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Levosalbutamol.
DB00834The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Mifepristone.
DB00648The serum concentration of Fluprednidene can be decreased when it is combined with Mitotane.
DB00266Fluprednidene may increase the anticoagulant activities of Dicoumarol.
DB00498Fluprednidene may increase the anticoagulant activities of Phenindione.
DB00682Fluprednidene may increase the anticoagulant activities of Warfarin.
DB00946Fluprednidene may increase the anticoagulant activities of Phenprocoumon.
DB01418Fluprednidene may increase the anticoagulant activities of Acenocoumarol.
DB03410Fluprednidene may increase the anticoagulant activities of 4-hydroxycoumarin.
DB04665Fluprednidene may increase the anticoagulant activities of Coumarin.
DB08496Fluprednidene may increase the anticoagulant activities of (R)-warfarin.
DB08794Fluprednidene may increase the anticoagulant activities of Ethyl biscoumacetate.
DB13136Fluprednidene may increase the anticoagulant activities of Fluindione.
DB13275Fluprednidene may increase the anticoagulant activities of Clorindione.
DB13347Fluprednidene may increase the anticoagulant activities of Diphenadione.
DB13451Fluprednidene may increase the anticoagulant activities of Tioclomarol.
DB14055Fluprednidene may increase the anticoagulant activities of (S)-Warfarin.
DB01015The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Fluprednidene.
DB01097The risk or severity of adverse effects can be increased when Fluprednidene is combined with Leflunomide.
DB08895Fluprednidene may increase the immunosuppressive activities of Tofacitinib.
DB00072Trastuzumab may increase the neutropenic activities of Fluprednidene.
DB08868Fluprednidene may increase the immunosuppressive activities of Fingolimod.
DB09220The risk or severity of ulceration can be increased when Fluprednidene is combined with Nicorandil.
DB00864Tacrolimus may increase the immunosuppressive activities of Fluprednidene.
DB00146The therapeutic efficacy of Calcifediol can be decreased when used in combination with Fluprednidene.
DB00153The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Fluprednidene.
DB01070The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Fluprednidene.
DB01436The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Fluprednidene.
DB04258The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Fluprednidene.
DB04796The therapeutic efficacy of Inecalcitol can be decreased when used in combination with Fluprednidene.
DB04891The therapeutic efficacy of Becocalcidiol can be decreased when used in combination with Fluprednidene.
DB05295The therapeutic efficacy of Eldecalcitol can be decreased when used in combination with Fluprednidene.
DB06117The therapeutic efficacy of 1alpha,24S-Dihydroxyvitamin D2 can be decreased when used in combination with Fluprednidene.
DB06194The therapeutic efficacy of Elocalcitol can be decreased when used in combination with Fluprednidene.
DB06272The therapeutic efficacy of Maxacalcitol can be decreased when used in combination with Fluprednidene.
DB06410The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Fluprednidene.
DB13097The therapeutic efficacy of 1alpha-Hydroxyvitamin D5 can be decreased when used in combination with Fluprednidene.
DB11094The therapeutic efficacy of Vitamin D can be decreased when used in combination with Fluprednidene.
DB00136The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluprednidene.
DB00169The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Fluprednidene.
DB00910The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluprednidene.
DB12025The serum concentration of Triptolide can be increased when it is combined with Fluprednidene.
DB00294The serum concentration of Etonogestrel can be increased when it is combined with Fluprednidene.
DB00304The serum concentration of Desogestrel can be increased when it is combined with Fluprednidene.
DB00351The serum concentration of Megestrol acetate can be increased when it is combined with Fluprednidene.
DB00367The serum concentration of Levonorgestrel can be increased when it is combined with Fluprednidene.
DB00717The serum concentration of Norethisterone can be increased when it is combined with Fluprednidene.
DB00823The serum concentration of Ethynodiol diacetate can be increased when it is combined with Fluprednidene.
DB00977The serum concentration of Ethinylestradiol can be increased when it is combined with Fluprednidene.
DB01357The serum concentration of Mestranol can be increased when it is combined with Fluprednidene.
DB04066The serum concentration of p-Coumaric acid can be increased when it is combined with Fluprednidene.
DB04574The serum concentration of Estrone sulfate can be increased when it is combined with Fluprednidene.
DB04682The serum concentration of Octylphenoxy polyethoxyethanol can be increased when it is combined with Fluprednidene.
DB04839The serum concentration of Cyproterone acetate can be increased when it is combined with Fluprednidene.
DB06266The serum concentration of Lonidamine can be increased when it is combined with Fluprednidene.
DB06713The serum concentration of Norelgestromin can be increased when it is combined with Fluprednidene.
DB06730The serum concentration of Gestodene can be increased when it is combined with Fluprednidene.
DB06789The serum concentration of Hydroxyprogesterone caproate can be increased when it is combined with Fluprednidene.
DB09371The serum concentration of Norethynodrel can be increased when it is combined with Fluprednidene.
DB09389The serum concentration of Norgestrel can be increased when it is combined with Fluprednidene.
DB09401The serum concentration of Isosorbide can be increased when it is combined with Fluprednidene.
DB11507The serum concentration of Cloprostenol can be increased when it is combined with Fluprednidene.
DB11619The serum concentration of Gestrinone can be increased when it is combined with Fluprednidene.
DB11636The serum concentration of Nomegestrol can be increased when it is combined with Fluprednidene.
DB12474The serum concentration of Lynestrenol can be increased when it is combined with Fluprednidene.
DB13044The serum concentration of Gossypol can be increased when it is combined with Fluprednidene.
DB13310The serum concentration of Ormeloxifene can be increased when it is combined with Fluprednidene.
DB13528The serum concentration of Chlormadinone can be increased when it is combined with Fluprednidene.
DB13563The serum concentration of Norgestrienone can be increased when it is combined with Fluprednidene.
DB13685The serum concentration of Quingestanol can be increased when it is combined with Fluprednidene.
DB13857The serum concentration of Demegestone can be increased when it is combined with Fluprednidene.
DB13866The serum concentration of Etynodiol can be increased when it is combined with Fluprednidene.
DB13981The serum concentration of Nomegestrol acetate can be increased when it is combined with Fluprednidene.
DB14678The serum concentration of Norethindrone enanthate can be increased when it is combined with Fluprednidene.
DB01395The serum concentration of Fluprednidene can be increased when it is combined with Drospirenone.
DB00396The serum concentration of Progesterone can be increased when it is combined with Fluprednidene.
DB00783The serum concentration of Estradiol can be increased when it is combined with Fluprednidene.
DB13953The serum concentration of Estradiol benzoate can be increased when it is combined with Fluprednidene.
DB13954The serum concentration of Estradiol cypionate can be increased when it is combined with Fluprednidene.
DB13956The serum concentration of Estradiol valerate can be increased when it is combined with Fluprednidene.
DB00255The serum concentration of Fluprednidene can be increased when it is combined with Diethylstilbestrol.
DB00603The serum concentration of Fluprednidene can be increased when it is combined with Medroxyprogesterone acetate.
DB00957The serum concentration of Fluprednidene can be increased when it is combined with Norgestimate.
DB08867The serum concentration of Fluprednidene can be increased when it is combined with Ulipristal.
DB00218The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Moxifloxacin.
DB00467The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Enoxacin.
DB00487The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Pefloxacin.
DB00685The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Trovafloxacin.
DB00779The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Nalidixic acid.
DB00817The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Rosoxacin.
DB00827The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Cinoxacin.
DB00978The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Lomefloxacin.
DB01044The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Gatifloxacin.
DB01155The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Gemifloxacin.
DB01165The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Ofloxacin.
DB01208The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Sparfloxacin.
DB01405The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Temafloxacin.
DB04576The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Fleroxacin.
DB05488The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Technetium Tc-99m ciprofloxacin.
DB06160The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Garenoxacin.
DB06600The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Nemonoxacin.
DB08972The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Flumequine.
DB11404The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Enrofloxacin.
DB11443The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Orbifloxacin.
DB11491The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Sarafloxacin.
DB11511The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Difloxacin.
DB11774The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Pazufloxacin.
DB11892The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Prulifloxacin.
DB13261The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Sitafloxacin.
DB13627The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Oxolinic acid.
DB13772The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Rufloxacin.
DB13823The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Pipemidic acid.
DB00365The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Grepafloxacin.
DB00537The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Ciprofloxacin.
DB01059The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Norfloxacin.
DB01137The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Levofloxacin.
DB11943The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Delafloxacin.
DB00310Fluprednidene may increase the hypokalemic activities of Chlorthalidone.
DB00524Fluprednidene may increase the hypokalemic activities of Metolazone.
DB00808Fluprednidene may increase the hypokalemic activities of Indapamide.
DB01325Fluprednidene may increase the hypokalemic activities of Quinethazone.
DB13989Fluprednidene may increase the hypokalemic activities of Epitizide.
DB00621The risk or severity of fluid retention can be increased when Fluprednidene is combined with Oxandrolone.
DB01185The risk or severity of fluid retention can be increased when Fluprednidene is combined with Fluoxymesterone.
DB06718The risk or severity of fluid retention can be increased when Fluprednidene is combined with Stanozolol.
DB12461The risk or severity of fluid retention can be increased when Fluprednidene is combined with GLPG-0492.
DB01406The risk or severity of fluid retention can be increased when Fluprednidene is combined with Danazol.
DB06412The risk or severity of fluid retention can be increased when Fluprednidene is combined with Oxymetholone.
DB01377The bioavailability of Fluprednidene can be decreased when combined with Magnesium oxide.
DB01390The bioavailability of Fluprednidene can be decreased when combined with Sodium bicarbonate.
DB06723The bioavailability of Fluprednidene can be decreased when combined with Aluminum hydroxide.
DB06724The bioavailability of Fluprednidene can be decreased when combined with Calcium carbonate.
DB08938The bioavailability of Fluprednidene can be decreased when combined with Magaldrate.
DB09104The bioavailability of Fluprednidene can be decreased when combined with Magnesium hydroxide.
DB09281The bioavailability of Fluprednidene can be decreased when combined with Magnesium trisilicate.
DB09481The bioavailability of Fluprednidene can be decreased when combined with Magnesium carbonate.
DB13249The bioavailability of Fluprednidene can be decreased when combined with Magnesium silicate.
DB13280The bioavailability of Fluprednidene can be decreased when combined with Aluminium acetoacetate.
DB13322The bioavailability of Fluprednidene can be decreased when combined with Hydrotalcite.
DB13486The bioavailability of Fluprednidene can be decreased when combined with Magnesium peroxide.
DB13595The bioavailability of Fluprednidene can be decreased when combined with Almasilate.
DB13626The bioavailability of Fluprednidene can be decreased when combined with Aluminium glycinate.
DB13650The bioavailability of Fluprednidene can be decreased when combined with Aloglutamol.
DB13829The bioavailability of Fluprednidene can be decreased when combined with Calcium silicate.
DB14517The bioavailability of Fluprednidene can be decreased when combined with Aluminium phosphate.
DB00214The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Torasemide.
DB00695The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Furosemide.
DB00887The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Bumetanide.
DB00903The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Etacrynic acid.
DB02925The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Piretanide.
DB08961The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Azosemide.
DB00328The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Fluprednidene.
DB00795The risk or severity of gastrointestinal irritation can be increased when Sulfasalazine is combined with Fluprednidene.
DB11466The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Tepoxalin.
DB00159The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Icosapent.
DB00461The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Nabumetone.
DB00465The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Ketorolac.
DB00469The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Tenoxicam.
DB00500The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Tolmetin.
DB00554The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Piroxicam.
DB00573The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Fenoprofen.
DB00605The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Sulindac.
DB00712The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Flurbiprofen.
DB00749The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Etodolac.
DB00784The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Mefenamic acid.
DB00788The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Naproxen.
DB00821The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Carprofen.
DB00939The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Meclofenamic acid.
DB00991The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Oxaprozin.
DB01009The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Ketoprofen.
DB01283The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Lumiracoxib.
DB01397The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Magnesium salicylate.
DB01399The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Salsalate.
DB01401The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Choline magnesium trisalicylate.
DB01419The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Antrafenine.
DB01600The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Tiaprofenic acid.
DB02224The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Taxifolin.
DB03585The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Oxyphenbutazone.
DB04725The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Licofelone.
DB04812The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Benoxaprofen.
DB05095The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Cimicoxib.
DB06725The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Lornoxicam.
DB06736The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Aceclofenac.
DB06737The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Zaltoprofen.
DB07402The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Azapropazone.
DB08797The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Salicylamide.
DB08940The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Kebuzone.
DB08942The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Isoxicam.
DB08951The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Indoprofen.
DB08955The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Ibuproxam.
DB08976The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Floctafenine.
DB08981The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Fenbufen.
DB08984The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Etofenamate.
DB08991The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Epirizole.
DB09084The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Benzydamine.
DB09213The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Dexibuprofen.
DB09214The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Dexketoprofen.
DB09215The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Droxicam.
DB09217The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Firocoxib.
DB09218The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Clonixin.
DB09285The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Morniflumate.
DB09295The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Talniflumate.
DB11455The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Robenacoxib.
DB11518The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Flunixin.
DB12399The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Polmacoxib.
DB12545The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Indobufen.
DB12610The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Ebselen.
DB13001The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Tinoridine.
DB13167The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Alclofenac.
DB13217The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Fentiazac.
DB13232The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Suxibuzone.
DB13286The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Bumadizone.
DB13314The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Alminoprofen.
DB13371The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Difenpiramide.
DB13407The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Nifenazone.
DB13432The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Lonazolac.
DB13481The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Tenidap.
DB13524The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Propyphenazone.
DB13527The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Proglumetacin.
DB13544The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Ethenzamide.
DB13629The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Mofebutazone.
DB13649The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Proquazone.
DB13657The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Benorilate.
DB13722The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Pirprofen.
DB13783The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Acemetacin.
DB13860The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Imidazole salicylate.
DB14059The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with SC-236.
DB14060The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with NS-398.
DB14938The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Flurbiprofen axetil.
DB00244The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Mesalazine.
DB00861The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Diflunisal.
DB00936The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Salicylic acid.
DB01014The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Balsalazide.
DB01250The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Olsalazine.
DB12445The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Nitroaspirin.
DB13538The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Guacetisal.
DB13612The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Carbaspirin calcium.
DB00482The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Celecoxib.
DB00533The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Rofecoxib.
DB00580The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Valdecoxib.
DB00586The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Diclofenac.
DB00812The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Phenylbutazone.
DB00814The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Meloxicam.
DB01050The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Ibuprofen.
DB01424The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Aminophenazone.
DB01435The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Antipyrine.
DB01628The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Etoricoxib.
DB04743The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Nimesulide.
DB04817The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Metamizole.
DB04828The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Zomepirac.
DB08439The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Parecoxib.
DB09216The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Tolfenamic acid.
DB09288The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Propacetamol.
DB09212The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Loxoprofen.
DB00515The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Cisplatin.
DB00888The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Mechlorethamine.
DB04572The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Thiotepa.
DB00871The therapeutic efficacy of Terbutaline can be decreased when used in combination with Fluprednidene.
DB01408The therapeutic efficacy of Bambuterol can be decreased when used in combination with Fluprednidene.
DB00382The therapeutic efficacy of Tacrine can be decreased when used in combination with Fluprednidene.
DB00391The therapeutic efficacy of Sulpiride can be decreased when used in combination with Fluprednidene.
DB00392The therapeutic efficacy of Profenamine can be decreased when used in combination with Fluprednidene.
DB00508The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Fluprednidene.
DB00527The therapeutic efficacy of Cinchocaine can be decreased when used in combination with Fluprednidene.
DB00585The therapeutic efficacy of Nizatidine can be decreased when used in combination with Fluprednidene.
DB00677The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Fluprednidene.
DB00711The therapeutic efficacy of Diethylcarbamazine can be decreased when used in combination with Fluprednidene.
DB00721The therapeutic efficacy of Procaine can be decreased when used in combination with Fluprednidene.
DB00805The therapeutic efficacy of Minaprine can be decreased when used in combination with Fluprednidene.
DB00941The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Fluprednidene.
DB00944The therapeutic efficacy of Demecarium can be decreased when used in combination with Fluprednidene.
DB00981The therapeutic efficacy of Physostigmine can be decreased when used in combination with Fluprednidene.
DB01010The therapeutic efficacy of Edrophonium can be decreased when used in combination with Fluprednidene.
DB01035The therapeutic efficacy of Procainamide can be decreased when used in combination with Fluprednidene.
DB01043The therapeutic efficacy of Memantine can be decreased when used in combination with Fluprednidene.
DB01122The therapeutic efficacy of Ambenonium can be decreased when used in combination with Fluprednidene.
DB01381The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Fluprednidene.
DB01400The therapeutic efficacy of Neostigmine can be decreased when used in combination with Fluprednidene.
DB02365The therapeutic efficacy of 1,10-Phenanthroline can be decreased when used in combination with Fluprednidene.
DB04864The therapeutic efficacy of Huperzine A can be decreased when used in combination with Fluprednidene.
DB04892The therapeutic efficacy of Phenserine can be decreased when used in combination with Fluprednidene.
DB05386The therapeutic efficacy of Regramostim can be decreased when used in combination with Fluprednidene.
DB06692The therapeutic efficacy of Aprotinin can be decreased when used in combination with Fluprednidene.
DB06756The therapeutic efficacy of Glycine betaine can be decreased when used in combination with Fluprednidene.
DB11390The therapeutic efficacy of Coumaphos can be decreased when used in combination with Fluprednidene.
DB11397The therapeutic efficacy of Dichlorvos can be decreased when used in combination with Fluprednidene.
DB11412The therapeutic efficacy of Fenthion can be decreased when used in combination with Fluprednidene.
DB11473The therapeutic efficacy of Metrifonate can be decreased when used in combination with Fluprednidene.
DB12482The therapeutic efficacy of Acotiamide can be decreased when used in combination with Fluprednidene.
DB13058The therapeutic efficacy of Methanesulfonyl Fluoride can be decreased when used in combination with Fluprednidene.
DB13495The therapeutic efficacy of Paraoxon can be decreased when used in combination with Fluprednidene.
DB13503The therapeutic efficacy of Tyrothricin can be decreased when used in combination with Fluprednidene.
DB13668The therapeutic efficacy of Ipidacrine can be decreased when used in combination with Fluprednidene.
DB13694The therapeutic efficacy of Distigmine can be decreased when used in combination with Fluprednidene.
DB14031The therapeutic efficacy of Tretamine can be decreased when used in combination with Fluprednidene.
DB15317The therapeutic efficacy of Posiphen can be decreased when used in combination with Fluprednidene.
DB00483The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Gallamine triethiodide.
DB01199The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Tubocurarine.
DB01245The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Decamethonium.
DB01337The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Pancuronium.
DB01338The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Pipecuronium.
DB00477The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Fluprednidene.
DB00545The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Fluprednidene.
DB00989The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Fluprednidene.
DB02845The therapeutic efficacy of Methylphosphinic Acid can be decreased when used in combination with Fluprednidene.
DB00082The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Fluprednidene.
DB00358The therapeutic efficacy of Mefloquine can be decreased when used in combination with Fluprednidene.
DB00674The therapeutic efficacy of Galantamine can be decreased when used in combination with Fluprednidene.
DB00843The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluprednidene.
DB01221The therapeutic efficacy of Ketamine can be decreased when used in combination with Fluprednidene.
DB01233The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Fluprednidene.
DB06774The therapeutic efficacy of Capsaicin can be decreased when used in combination with Fluprednidene.
DB00202The risk or severity of myopathy and weakness can be increased when Succinylcholine is combined with Fluprednidene.
DB00416The risk or severity of myopathy and weakness can be increased when Metocurine iodide is combined with Fluprednidene.
DB00565The risk or severity of myopathy and weakness can be increased when Cisatracurium is combined with Fluprednidene.
DB00728The risk or severity of myopathy and weakness can be increased when Rocuronium is combined with Fluprednidene.
DB00732The risk or severity of myopathy and weakness can be increased when Atracurium besylate is combined with Fluprednidene.
DB01135The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fluprednidene.
DB01226The risk or severity of myopathy and weakness can be increased when Mivacurium is combined with Fluprednidene.
DB01336The risk or severity of myopathy and weakness can be increased when Metocurine is combined with Fluprednidene.
DB01339The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Fluprednidene.
DB04834The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluprednidene.
DB11156The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Fluprednidene.
DB12989The risk or severity of myopathy and weakness can be increased when Neosaxitoxin is combined with Fluprednidene.
DB13295The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Fluprednidene.
DB13584The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Fluprednidene.
DB13648The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Fluprednidene.
DB03793The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Fluprednidene.
DB06819The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Fluprednidene.
DB08909The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Fluprednidene.
DB09269The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Fluprednidene.
DB01108The risk or severity of edema formation can be increased when Trilostane is combined with Fluprednidene.
DB00624The risk or severity of edema formation can be increased when Testosterone is combined with Fluprednidene.
DB00984The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Fluprednidene.
DB01420The risk or severity of edema formation can be increased when Testosterone propionate is combined with Fluprednidene.
DB01434The risk or severity of edema formation can be increased when 19-norandrostenedione is combined with Fluprednidene.
DB01456The risk or severity of edema formation can be increased when 5-androstenedione is combined with Fluprednidene.
DB01471The risk or severity of edema formation can be increased when Bolasterone is combined with Fluprednidene.
DB01481The risk or severity of edema formation can be increased when 1-Testosterone is combined with Fluprednidene.
DB01485The risk or severity of edema formation can be increased when 4-Hydroxytestosterone is combined with Fluprednidene.
DB01521The risk or severity of edema formation can be increased when Clostebol is combined with Fluprednidene.
DB01524The risk or severity of edema formation can be increased when Androstenediol is combined with Fluprednidene.
DB01536The risk or severity of edema formation can be increased when Androstenedione is combined with Fluprednidene.
DB01541The risk or severity of edema formation can be increased when Boldenone is combined with Fluprednidene.
DB01554The risk or severity of edema formation can be increased when Bolandiol is combined with Fluprednidene.
DB01564The risk or severity of edema formation can be increased when Calusterone is combined with Fluprednidene.
DB05107The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Fluprednidene.
DB05804The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Fluprednidene.
DB05830The risk or severity of edema formation can be increased when Trestolone is combined with Fluprednidene.
DB06250The risk or severity of edema formation can be increased when Fluasterone is combined with Fluprednidene.
DB06710The risk or severity of edema formation can be increased when Methyltestosterone is combined with Fluprednidene.
DB07768The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluprednidene.
DB08619The risk or severity of edema formation can be increased when Testosterone succinate is combined with Fluprednidene.
DB08804The risk or severity of edema formation can be increased when Nandrolone decanoate is combined with Fluprednidene.
DB08905The risk or severity of edema formation can be increased when Formestane is combined with Fluprednidene.
DB09123The risk or severity of edema formation can be increased when Dienogest is combined with Fluprednidene.
DB11429The risk or severity of edema formation can be increased when Mibolerone is combined with Fluprednidene.
DB12194The risk or severity of edema formation can be increased when Atamestane is combined with Fluprednidene.
DB13169The risk or severity of edema formation can be increased when Nandrolone is combined with Fluprednidene.
DB13587The risk or severity of edema formation can be increased when Mesterolone is combined with Fluprednidene.
DB13710The risk or severity of edema formation can be increased when Metenolone is combined with Fluprednidene.
DB13943The risk or severity of edema formation can be increased when Testosterone cypionate is combined with Fluprednidene.
DB13944The risk or severity of edema formation can be increased when Testosterone enanthate is combined with Fluprednidene.
DB13946The risk or severity of edema formation can be increased when Testosterone undecanoate is combined with Fluprednidene.
DB13947The risk or severity of edema formation can be increased when Testosterone enantate benzilic acid hydrazone is combined with Fluprednidene.
DB13958The risk or severity of edema formation can be increased when Trestolone acetate is combined with Fluprednidene.
DB11988Ocrelizumab may increase the immunosuppressive activities of Fluprednidene.
DB11642The serum concentration of Fluprednidene can be decreased when it is combined with Pitolisant.
DB09046The metabolism of Fluprednidene can be increased when combined with Metreleptin.
DB00186The metabolism of Lorazepam can be increased when combined with Fluprednidene.
DB00191The metabolism of Phentermine can be increased when combined with Fluprednidene.
DB00207The metabolism of Azithromycin can be increased when combined with Fluprednidene.
DB00208The metabolism of Ticlopidine can be increased when combined with Fluprednidene.
DB00246The metabolism of Ziprasidone can be increased when combined with Fluprednidene.
DB00264The metabolism of Metoprolol can be increased when combined with Fluprednidene.
DB00426The metabolism of Famciclovir can be increased when combined with Fluprednidene.
DB00433The metabolism of Prochlorperazine can be increased when combined with Fluprednidene.
DB00476The metabolism of Duloxetine can be increased when combined with Fluprednidene.
DB00518The metabolism of Albendazole can be increased when combined with Fluprednidene.
DB00567The metabolism of Cephalexin can be increased when combined with Fluprednidene.
DB00590The metabolism of Doxazosin can be increased when combined with Fluprednidene.
DB01039The metabolism of Fenofibrate can be increased when combined with Fluprednidene.
DB01411The metabolism of Pranlukast can be increased when combined with Fluprednidene.
DB01431The metabolism of Allylestrenol can be increased when combined with Fluprednidene.
DB01624The metabolism of Zuclopenthixol can be increased when combined with Fluprednidene.
DB06201The metabolism of Rufinamide can be increased when combined with Fluprednidene.
DB06218The metabolism of Lacosamide can be increased when combined with Fluprednidene.
DB06480The metabolism of Prucalopride can be increased when combined with Fluprednidene.
DB09030The metabolism of Vorapaxar can be increased when combined with Fluprednidene.
DB09034The metabolism of Suvorexant can be increased when combined with Fluprednidene.
DB09048The metabolism of Netupitant can be increased when combined with Fluprednidene.
DB09071The metabolism of Tasimelteon can be increased when combined with Fluprednidene.
DB09079The metabolism of Nintedanib can be increased when combined with Fluprednidene.
DB09299The metabolism of Tenofovir alafenamide can be increased when combined with Fluprednidene.
DB11273The metabolism of Dihydroergocornine can be increased when combined with Fluprednidene.
DB11952The metabolism of Duvelisib can be increased when combined with Fluprednidene.
DB12141The metabolism of Gilteritinib can be increased when combined with Fluprednidene.
DB12515The metabolism of 9-aminocamptothecin can be increased when combined with Fluprednidene.
DB12952The metabolism of Methylprednisone can be increased when combined with Fluprednidene.
DB13345The metabolism of Dihydroergocristine can be increased when combined with Fluprednidene.
DB13385The metabolism of Dihydroergocryptine can be increased when combined with Fluprednidene.
DB14009The metabolism of Medical Cannabis can be increased when combined with Fluprednidene.
DB14126The metabolism of Tenofovir can be increased when combined with Fluprednidene.
DB00549The metabolism of Fluprednidene can be increased when combined with Zafirlukast.
DB01098The metabolism of Rosuvastatin can be increased when combined with Fluprednidene.
DB01072The metabolism of Atazanavir can be increased when combined with Fluprednidene.
DB01323The metabolism of St. John's Wort can be increased when combined with Fluprednidene.
DB11730The metabolism of Ribociclib can be increased when combined with Fluprednidene.
DB15444The metabolism of Elexacaftor can be increased when combined with Fluprednidene.
DB12887The metabolism of Tazemetostat can be increased when combined with Fluprednidene.
DB06717The metabolism of Fosaprepitant can be increased when combined with Fluprednidene.
DB12825The metabolism of Lefamulin can be increased when combined with Fluprednidene.
DB00247The metabolism of Methysergide can be increased when combined with Fluprednidene.
DB00454The metabolism of Meperidine can be increased when combined with Fluprednidene.
DB11742The metabolism of Ebastine can be increased when combined with Fluprednidene.
DB00342The metabolism of Terfenadine can be increased when combined with Fluprednidene.
DB00604The metabolism of Cisapride can be increased when combined with Fluprednidene.
DB11633The metabolism of Isavuconazole can be increased when combined with Fluprednidene.
DB00188The metabolism of Fluprednidene can be increased when combined with Bortezomib.
DB00309The metabolism of Fluprednidene can be increased when combined with Vindesine.
DB00361The metabolism of Fluprednidene can be increased when combined with Vinorelbine.
DB00398The metabolism of Fluprednidene can be increased when combined with Sorafenib.
DB00444The metabolism of Fluprednidene can be increased when combined with Teniposide.
DB00531The metabolism of Fluprednidene can be increased when combined with Cyclophosphamide.
DB00541The metabolism of Fluprednidene can be increased when combined with Vincristine.
DB00570The metabolism of Fluprednidene can be increased when combined with Vinblastine.
DB00762The metabolism of Fluprednidene can be increased when combined with Irinotecan.
DB00773The metabolism of Fluprednidene can be increased when combined with Etoposide.
DB00997The metabolism of Fluprednidene can be increased when combined with Doxorubicin.
DB01248The metabolism of Fluprednidene can be increased when combined with Docetaxel.
DB04845The metabolism of Fluprednidene can be increased when combined with Ixabepilone.
DB04868The metabolism of Fluprednidene can be increased when combined with Nilotinib.
DB05109The metabolism of Fluprednidene can be increased when combined with Trabectedin.
DB05773The metabolism of Fluprednidene can be increased when combined with Trastuzumab emtansine.
DB06589The metabolism of Fluprednidene can be increased when combined with Pazopanib.
DB06603The metabolism of Fluprednidene can be increased when combined with Panobinostat.
DB06616The metabolism of Fluprednidene can be increased when combined with Bosutinib.
DB06772The metabolism of Fluprednidene can be increased when combined with Cabazitaxel.
DB08870The metabolism of Fluprednidene can be increased when combined with Brentuximab vedotin.
DB08877The metabolism of Fluprednidene can be increased when combined with Ruxolitinib.
DB08901The metabolism of Fluprednidene can be increased when combined with Ponatinib.
DB08910The metabolism of Fluprednidene can be increased when combined with Pomalidomide.
DB09054The metabolism of Idelalisib can be increased when combined with Fluprednidene.
DB09073The metabolism of Palbociclib can be increased when combined with Fluprednidene.
DB09074The metabolism of Olaparib can be increased when combined with Fluprednidene.
DB11817The metabolism of Baricitinib can be increased when combined with Fluprednidene.
DB01181The metabolism of Fluprednidene can be increased when combined with Ifosfamide.
DB05239The metabolism of Cobimetinib can be increased when combined with Fluprednidene.
DB09330The metabolism of Osimertinib can be increased when combined with Fluprednidene.
DB11963The metabolism of Dacomitinib can be increased when combined with Fluprednidene.
DB12015The metabolism of Alpelisib can be increased when combined with Fluprednidene.
DB01100The metabolism of Pimozide can be increased when combined with Fluprednidene.
DB01118The metabolism of Amiodarone can be increased when combined with Fluprednidene.
DB00530The metabolism of Erlotinib can be increased when combined with Fluprednidene.
DB00564The metabolism of Carbamazepine can be increased when combined with Fluprednidene.
DB00675The metabolism of Tamoxifen can be increased when combined with Fluprednidene.
DB00877The metabolism of Sirolimus can be increased when combined with Fluprednidene.
DB01229The metabolism of Paclitaxel can be increased when combined with Fluprednidene.
DB01254The metabolism of Dasatinib can be increased when combined with Fluprednidene.
DB04855The metabolism of Dronedarone can be increased when combined with Fluprednidene.
DB06176The metabolism of Romidepsin can be increased when combined with Fluprednidene.
DB06287The metabolism of Temsirolimus can be increased when combined with Fluprednidene.
DB06626The metabolism of Axitinib can be increased when combined with Fluprednidene.
DB08865The metabolism of Crizotinib can be increased when combined with Fluprednidene.
DB12483The metabolism of Copanlisib can be increased when combined with Fluprednidene.
DB00204The metabolism of Dofetilide can be increased when combined with Fluprednidene.
DB00277The metabolism of Theophylline can be increased when combined with Fluprednidene.
DB00908The metabolism of Quinidine can be increased when combined with Fluprednidene.
DB01008The metabolism of Busulfan can be increased when combined with Fluprednidene.
DB01223The metabolism of Aminophylline can be increased when combined with Fluprednidene.
DB01590The metabolism of Everolimus can be increased when combined with Fluprednidene.
DB09289The metabolism of Tianeptine can be increased when combined with Fluprednidene.
DB00563The metabolism of Fluprednidene can be increased when combined with Methotrexate.
DB00575The metabolism of Clonidine can be increased when combined with Fluprednidene.
DB00637The metabolism of Astemizole can be increased when combined with Fluprednidene.
DB12371The metabolism of Siponimod can be increased when combined with Fluprednidene.
DB08827The metabolism of Lomitapide can be increased when combined with Fluprednidene.
DB05294The metabolism of Vandetanib can be increased when combined with Fluprednidene.
DB08881The metabolism of Vemurafenib can be increased when combined with Fluprednidene.
DB11363The metabolism of Alectinib can be increased when combined with Fluprednidene.
DB11581The metabolism of Venetoclax can be increased when combined with Fluprednidene.
DB11641The metabolism of Vinflunine can be increased when combined with Fluprednidene.
DB11703The metabolism of Acalabrutinib can be increased when combined with Fluprednidene.
DB13874The metabolism of Enasidenib can be increased when combined with Fluprednidene.
DB15035The metabolism of Zanubrutinib can be increased when combined with Fluprednidene.
DB00248The metabolism of Cabergoline can be increased when combined with Fluprednidene.
DB06595The metabolism of Midostaurin can be increased when combined with Fluprednidene.
DB08912The metabolism of Dabrafenib can be increased when combined with Fluprednidene.
DB09143The metabolism of Sonidegib can be increased when combined with Fluprednidene.
DB09570The metabolism of Ixazomib can be increased when combined with Fluprednidene.
DB11828The metabolism of Neratinib can be increased when combined with Fluprednidene.
DB12147The metabolism of Erdafitinib can be increased when combined with Fluprednidene.
DB12267The metabolism of Brigatinib can be increased when combined with Fluprednidene.
DB12978The metabolism of Pexidartinib can be increased when combined with Fluprednidene.
DB14568The metabolism of Ivosidenib can be increased when combined with Fluprednidene.
DB06212The metabolism of Tolvaptan can be increased when combined with Fluprednidene.
DB08896The metabolism of Regorafenib can be increased when combined with Fluprednidene.
DB12001The metabolism of Abemaciclib can be increased when combined with Fluprednidene.
DB00320The metabolism of Dihydroergotamine can be increased when combined with Fluprednidene.
DB00696The metabolism of Ergotamine can be increased when combined with Fluprednidene.
DB00872The metabolism of Conivaptan can be increased when combined with Fluprednidene.
DB01128The metabolism of Bicalutamide can be increased when combined with Fluprednidene.
DB01242The metabolism of Clomipramine can be increased when combined with Fluprednidene.
DB00540The metabolism of Nortriptyline can be increased when combined with Fluprednidene.
DB01227The metabolism of Levacetylmethadol can be increased when combined with Fluprednidene.
DB12130The metabolism of Lorlatinib can be increased when combined with Fluprednidene.
DB01224The metabolism of Quetiapine can be increased when combined with Fluprednidene.
DB01126The metabolism of Dutasteride can be increased when combined with Fluprednidene.
DB11757The metabolism of Istradefylline can be increased when combined with Fluprednidene.
DB04856The metabolism of Dexloxiglumide can be increased when combined with Fluprednidene.
DB04957The metabolism of Azimilide can be increased when combined with Fluprednidene.
DB00199The metabolism of Erythromycin can be increased when combined with Fluprednidene.
DB00238The metabolism of Nevirapine can be increased when combined with Fluprednidene.
DB00250The metabolism of Dapsone can be increased when combined with Fluprednidene.
DB00281The metabolism of Lidocaine can be increased when combined with Fluprednidene.
DB00317The metabolism of Gefitinib can be increased when combined with Fluprednidene.
DB00333The metabolism of Methadone can be increased when combined with Fluprednidene.
DB00343The metabolism of Diltiazem can be increased when combined with Fluprednidene.
DB00439The metabolism of Cerivastatin can be increased when combined with Fluprednidene.
DB00497The metabolism of Oxycodone can be increased when combined with Fluprednidene.
DB00499The metabolism of Flutamide can be increased when combined with Fluprednidene.
DB00514The metabolism of Dextromethorphan can be increased when combined with Fluprednidene.
DB00528The metabolism of Lercanidipine can be increased when combined with Fluprednidene.
DB00571The metabolism of Propranolol can be increased when combined with Fluprednidene.
DB00608The metabolism of Chloroquine can be increased when combined with Fluprednidene.
DB00656The metabolism of Trazodone can be increased when combined with Fluprednidene.
DB00661The metabolism of Verapamil can be increased when combined with Fluprednidene.
DB00701The metabolism of Amprenavir can be increased when combined with Fluprednidene.
DB00734The metabolism of Risperidone can be increased when combined with Fluprednidene.
DB00758The metabolism of Clopidogrel can be increased when combined with Fluprednidene.
DB00822The metabolism of Disulfiram can be increased when combined with Fluprednidene.
DB00829The metabolism of Diazepam can be increased when combined with Fluprednidene.
DB00904The metabolism of Ondansetron can be increased when combined with Fluprednidene.
DB00909The metabolism of Zonisamide can be increased when combined with Fluprednidene.
DB00916The metabolism of Metronidazole can be increased when combined with Fluprednidene.
DB00921The metabolism of Buprenorphine can be increased when combined with Fluprednidene.
DB00962The metabolism of Zaleplon can be increased when combined with Fluprednidene.
DB00972The metabolism of Azelastine can be increased when combined with Fluprednidene.
DB00976The metabolism of Telithromycin can be increased when combined with Fluprednidene.
DB01054The metabolism of Nitrendipine can be increased when combined with Fluprednidene.
DB01058The metabolism of Praziquantel can be increased when combined with Fluprednidene.
DB01062The metabolism of Oxybutynin can be increased when combined with Fluprednidene.
DB01076The metabolism of Atorvastatin can be increased when combined with Fluprednidene.
DB01095The metabolism of Fluvastatin can be increased when combined with Fluprednidene.
DB01103The metabolism of Quinacrine can be increased when combined with Fluprednidene.
DB01114The metabolism of Chlorpheniramine can be increased when combined with Fluprednidene.
DB01166The metabolism of Cilostazol can be increased when combined with Fluprednidene.
DB01184The metabolism of Domperidone can be increased when combined with Fluprednidene.
DB01211The metabolism of Clarithromycin can be increased when combined with Fluprednidene.
DB01216The metabolism of Finasteride can be increased when combined with Fluprednidene.
DB01218The metabolism of Halofantrine can be increased when combined with Fluprednidene.
DB01238The metabolism of Aripiprazole can be increased when combined with Fluprednidene.
DB01259The metabolism of Lapatinib can be increased when combined with Fluprednidene.
DB01267The metabolism of Paliperidone can be increased when combined with Fluprednidene.
DB04946The metabolism of Iloperidone can be increased when combined with Fluprednidene.
DB05521The metabolism of Telaprevir can be increased when combined with Fluprednidene.
DB06267The metabolism of Udenafil can be increased when combined with Fluprednidene.
DB06403The metabolism of Ambrisentan can be increased when combined with Fluprednidene.
DB06419The metabolism of Cethromycin can be increased when combined with Fluprednidene.
DB06605The metabolism of Apixaban can be increased when combined with Fluprednidene.
DB06652The metabolism of Vicriviroc can be increased when combined with Fluprednidene.
DB06697The metabolism of Artemether can be increased when combined with Fluprednidene.
DB08820The metabolism of Ivacaftor can be increased when combined with Fluprednidene.
DB08873The metabolism of Boceprevir can be increased when combined with Fluprednidene.
DB08883The metabolism of Perampanel can be increased when combined with Fluprednidene.
DB08899The metabolism of Enzalutamide can be increased when combined with Fluprednidene.
DB09061The metabolism of Cannabidiol can be increased when combined with Fluprednidene.
DB09065The metabolism of Cobicistat can be increased when combined with Fluprednidene.
DB09068The metabolism of Vortioxetine can be increased when combined with Fluprednidene.
DB09102The metabolism of Daclatasvir can be increased when combined with Fluprednidene.
DB09231The metabolism of Benidipine can be increased when combined with Fluprednidene.
DB09297The metabolism of Paritaprevir can be increased when combined with Fluprednidene.
DB11574The metabolism of Elbasvir can be increased when combined with Fluprednidene.
DB11586The metabolism of Asunaprevir can be increased when combined with Fluprednidene.
DB11712The metabolism of Tezacaftor can be increased when combined with Fluprednidene.
DB11737The metabolism of Icotinib can be increased when combined with Fluprednidene.
DB11915The metabolism of Valbenazine can be increased when combined with Fluprednidene.
DB12161The metabolism of Deutetrabenazine can be increased when combined with Fluprednidene.
DB12301The metabolism of Doravirine can be increased when combined with Fluprednidene.
DB13952The metabolism of Estradiol acetate can be increased when combined with Fluprednidene.
DB13955The metabolism of Estradiol dienanthate can be increased when combined with Fluprednidene.
DB14011The metabolism of Nabiximols can be increased when combined with Fluprednidene.
DB14185The metabolism of Aripiprazole lauroxil can be increased when combined with Fluprednidene.
DB09237The metabolism of Levamlodipine can be increased when combined with Fluprednidene.
DB11951The metabolism of Lemborexant can be increased when combined with Fluprednidene.
DB00557The metabolism of Hydroxyzine can be increased when combined with Fluprednidene.
DB01115The metabolism of Nifedipine can be increased when combined with Fluprednidene.
DB00203The metabolism of Sildenafil can be increased when combined with Fluprednidene.
DB00227The metabolism of Lovastatin can be increased when combined with Fluprednidene.
DB00490The metabolism of Buspirone can be increased when combined with Fluprednidene.
DB00641The metabolism of Simvastatin can be increased when combined with Fluprednidene.
DB00673The metabolism of Aprepitant can be increased when combined with Fluprednidene.
DB00820The metabolism of Tadalafil can be increased when combined with Fluprednidene.
DB00862The metabolism of Vardenafil can be increased when combined with Fluprednidene.
DB01190The metabolism of Clindamycin can be increased when combined with Fluprednidene.
DB00321The metabolism of Amitriptyline can be increased when combined with Fluprednidene.
DB00224The metabolism of Indinavir can be increased when combined with Fluprednidene.
DB00401The metabolism of Nisoldipine can be increased when combined with Fluprednidene.
DB00404The metabolism of Alprazolam can be increased when combined with Fluprednidene.
DB00683The metabolism of Midazolam can be increased when combined with Fluprednidene.
DB00700The metabolism of Eplerenone can be increased when combined with Fluprednidene.
DB00802The metabolism of Alfentanil can be increased when combined with Fluprednidene.
DB00813The metabolism of Fentanyl can be increased when combined with Fluprednidene.
DB00897The metabolism of Triazolam can be increased when combined with Fluprednidene.
DB01023The metabolism of Felodipine can be increased when combined with Fluprednidene.
DB01232The metabolism of Saquinavir can be increased when combined with Fluprednidene.
DB06228The metabolism of Rivaroxaban can be increased when combined with Fluprednidene.
DB11689The metabolism of Selumetinib can be increased when combined with Fluprednidene.
DB00714The metabolism of Apomorphine can be increased when combined with Fluprednidene.
DB00741The metabolism of Hydrocortisone can be increased when combined with Fluprednidene.
DB14541The metabolism of Hydrocortisone cypionate can be increased when combined with Fluprednidene.
DB00655The metabolism of Estrone can be increased when combined with Fluprednidene.
DB06448The metabolism of Lonafarnib can be increased when combined with Fluprednidene.
DB14542The metabolism of Hydrocortisone phosphate can be increased when combined with Fluprednidene.
DB09256The metabolism of Tegafur can be increased when combined with Fluprednidene.
DB00091Fluprednidene may increase the immunosuppressive activities of Cyclosporine.
DB13074The therapeutic efficacy of Macimorelin can be decreased when used in combination with Fluprednidene.
DB00381The metabolism of Amlodipine can be increased when combined with Fluprednidene.
DB00024The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluprednidene.
DB00279The therapeutic efficacy of Liothyronine can be decreased when used in combination with Fluprednidene.
DB01583The therapeutic efficacy of Liotrix can be decreased when used in combination with Fluprednidene.
DB03604The therapeutic efficacy of Tiratricol can be decreased when used in combination with Fluprednidene.
DB09100The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Fluprednidene.
DB00451The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Fluprednidene.
DB00425The metabolism of Zolpidem can be increased when combined with Fluprednidene.
DB00331The therapeutic efficacy of Metformin can be decreased when used in combination with Fluprednidene.
DB00945The risk or severity of adverse effects can be increased when Fluprednidene is combined with Acetylsalicylic acid.
DB11986The metabolism of Entrectinib can be increased when combined with Fluprednidene.
DB01432Cholestyramine may increase the excretion rate of Fluprednidene which could result in a lower serum level and potentially a reduction in efficacy.
DB00388The risk or severity of hypertension can be increased when Fluprednidene is combined with Phenylephrine.
DB00357The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Aminoglutethimide.
DB01268The risk or severity of hyperglycemia can be increased when Sunitinib is combined with Fluprednidene.
DB00030The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin human.
DB00046The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin lispro.
DB00047The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin glargine.
DB00071The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin pork.
DB00197The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Troglitazone.
DB00222The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glimepiride.
DB00263The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Sulfisoxazole.
DB00280The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Disopyramide.
DB00284The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Acarbose.
DB00359The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Sulfadiazine.
DB00412The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Rosiglitazone.
DB00414The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Acetohexamide.
DB00468The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Quinine.
DB00491The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Miglitol.
DB00672The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Chlorpropamide.
DB00731The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Nateglinide.
DB00738The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Pentamidine.
DB00839The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Tolazamide.
DB00912The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Repaglinide.
DB00914The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Phenformin.
DB01016The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glyburide.
DB01067The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glipizide.
DB01120The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Gliclazide.
DB01124The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Tolbutamide.
DB01132The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Pioglitazone.
DB01251The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Gliquidone.
DB01252The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Mitiglinide.
DB01261The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Sitagliptin.
DB01276The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Exenatide.
DB01277The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Mecasermin.
DB01278The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Pramlintide.
DB01289The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glisoxepide.
DB01306The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin aspart.
DB01307The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin detemir.
DB01309The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin glulisine.
DB01382The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glymidine.
DB01700The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with AICA ribonucleotide.
DB04830The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Buformin.
DB04876The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Vildagliptin.
DB04878The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Voglibose.
DB05115The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with NN344.
DB05819The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with NBI-6024.
DB06011The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with AMG-222.
DB06127The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Bisegliptin.
DB06203The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Alogliptin.
DB06292The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Dapagliflozin.
DB06335The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Saxagliptin.
DB06655The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Liraglutide.
DB08382The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Gosogliptin.
DB08882The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Linagliptin.
DB08907The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Canagliflozin.
DB08962The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glibornuride.
DB09022The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Benfluorex.
DB09038The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Empagliflozin.
DB09043The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Albiglutide.
DB09045The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Dulaglutide.
DB09198The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Lobeglitazone.
DB09199The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Netoglitazone.
DB09200The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Rivoglitazone.
DB09201The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Ciglitazone.
DB09265The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Lixisenatide.
DB09456The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin beef.
DB09564The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin degludec.
DB11567The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin peglispro.
DB11568The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin tregopil.
DB11698The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Ipragliflozin.
DB11723The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Dutogliptin.
DB11780The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Allicin.
DB11824The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Tofogliflozin.
DB11827The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Ertugliflozin.
DB11898The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with 2,4-thiazolidinedione.
DB11950The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Teneligliptin.
DB11992The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Omarigliptin.
DB12268The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Carmegliptin.
DB12412The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Gemigliptin.
DB12417The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Anagliptin.
DB12625The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Evogliptin.
DB12713The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Sotagliflozin.
DB12781The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Balaglitazone.
DB12935The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Remogliflozin etabonate.
DB13406The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Carbutamide.
DB13446The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Guar gum.
DB13675The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Metahexamide.
DB13928The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Semaglutide.
DB14027The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Taspoglutide.
DB14035The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Englitazone.
DB15171The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Tirzepatide.
DB15217The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Gastric inhibitory polypeptide.
DB01200The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Bromocriptine.
DB00951The serum concentration of Isoniazid can be decreased when it is combined with Fluprednidene.
DB01396The risk or severity of adverse effects can be increased when Fluprednidene is combined with Digitoxin.
DB00390The risk or severity of adverse effects can be increased when Fluprednidene is combined with Digoxin.
DB00511The risk or severity of adverse effects can be increased when Fluprednidene is combined with Acetyldigitoxin.
DB01078The risk or severity of adverse effects can be increased when Fluprednidene is combined with Deslanoside.
DB13401The risk or severity of adverse effects can be increased when Fluprednidene is combined with Metildigoxin.
DB13467The risk or severity of adverse effects can be increased when Fluprednidene is combined with Lanatoside C.
DB13537The risk or severity of adverse effects can be increased when Fluprednidene is combined with Gitoformate.
DB13691The risk or severity of adverse effects can be increased when Fluprednidene is combined with Acetyldigoxin.
DB04914The therapeutic efficacy of G17DT can be decreased when used in combination with Fluprednidene.
DB05144The therapeutic efficacy of PEV3A can be decreased when used in combination with Fluprednidene.
DB05325The therapeutic efficacy of INGN 225 can be decreased when used in combination with Fluprednidene.
DB05374The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Fluprednidene.
DB05440The therapeutic efficacy of SRP 299 can be decreased when used in combination with Fluprednidene.
DB05942The therapeutic efficacy of GI-5005 can be decreased when used in combination with Fluprednidene.
DB06400The therapeutic efficacy of Vitespen can be decreased when used in combination with Fluprednidene.
DB06584The therapeutic efficacy of TG4010 can be decreased when used in combination with Fluprednidene.
DB09057The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Fluprednidene.
DB10062The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Fluprednidene.
DB10076The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Fluprednidene.
DB10276The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Fluprednidene.
DB10283The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Fluprednidene.
DB10342The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Fluprednidene.
DB10583The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluprednidene.
DB10584The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluprednidene.
DB10600The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Fluprednidene.
DB10769The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Fluprednidene.
DB10794The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Fluprednidene.
DB10803The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Fluprednidene.
DB10989The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Fluprednidene.
DB10990The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Fluprednidene.
DB11038The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Fluprednidene.
DB11040The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Fluprednidene.
DB11041The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Fluprednidene.
DB11044The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Fluprednidene.
DB11603The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Fluprednidene.
DB11627The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Fluprednidene.
DB12568The therapeutic efficacy of Tecemotide can be decreased when used in combination with Fluprednidene.
DB14022The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Fluprednidene.
DB14384The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Fluprednidene.
DB14385The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Fluprednidene.
DB14394The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Fluprednidene.
DB14445The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Fluprednidene.
DB14449The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Fluprednidene.
DB14619The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Fluprednidene.
DB14620The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Fluprednidene.
DB14711The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Fluprednidene.
DB15274The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Fluprednidene.
DB15461The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Fluprednidene.
DB10317The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Rubella virus vaccine.
DB10318The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Varicella Zoster Vaccine (Live/attenuated).
DB10343The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Bacillus calmette-guerin substrain tice live antigen.
DB10804The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Bacillus calmette-guerin substrain connaught live antigen.
DB10805The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Yellow Fever Vaccine.
DB11003The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Anthrax vaccine.
DB11050The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Typhoid Vaccine Live.
DB12386The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Bacillus calmette-guerin substrain danish 1331 live antigen.
DB12768The therapeutic efficacy of Fluprednidene can be decreased when used in combination with BCG vaccine.
DB14409The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Human adenovirus e serotype 4 strain cl-68578 antigen.
DB14443The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Vibrio cholerae CVD 103-HgR strain live antigen.
DB14685The therapeutic efficacy of Fluprednidene can be decreased when used in combination with Adenovirus type 7 vaccine live.
DB13924The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Fluprednidene.
DB15483The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Fluprednidene.
DB15595The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Fluprednidene.
DB15654The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Fluprednidene.
DB06119The serum concentration of Cenobamate can be decreased when it is combined with Fluprednidene.
DB01364Ephedrine may increase the excretion rate of Fluprednidene which could result in a lower serum level and potentially a reduction in efficacy.
DB00052The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluprednidene.
DB01320The serum concentration of Fosphenytoin can be decreased when it is combined with Fluprednidene.
DB00252The serum concentration of Fluprednidene can be decreased when it is combined with Phenytoin.
DB14513The serum concentration of Magnesium can be decreased when it is combined with Fluprednidene.
DB01601The serum concentration of Fluprednidene can be increased when it is combined with Lopinavir.
DB00503The serum concentration of Ritonavir can be increased when it is combined with Fluprednidene.
DB00232The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Methyclothiazide.
DB00436The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Bendroflumethiazide.
DB00562The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Benzthiazide.
DB00774The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Hydroflumethiazide.
DB00880The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Chlorothiazide.
DB00999The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Hydrochlorothiazide.
DB01021The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Trichlormethiazide.
DB01324The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Polythiazide.
DB13532The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Cyclopenthiazide.
DB00606The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Cyclothiazide.
DB13430The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Mebutizide.
DB00502The serum concentration of Haloperidol can be increased when it is combined with Fluprednidene.
DB11652The metabolism of Tucatinib can be decreased when combined with Fluprednidene.
DB12530The risk or severity of infection can be increased when Fluprednidene is combined with Inebilizumab.
DB11932The serum concentration of Fluprednidene can be increased when it is combined with Abametapir.
DB15762The serum concentration of Fluprednidene can be decreased when it is combined with Satralizumab.
DB15093The serum concentration of the active metabolites of Fluprednidene can be decreased when Fluprednidene is used in combination with Somapacitan.